U.S. Professional Services Stock News

If you are wondering whether STAAR Surgical's share price reflects its true value today, it helps to step back and look at how the market has been treating the stock recently. Over the last week, the share price return was 8.7% lower. The 30 day, year to date and 1 year returns were 18.0%, 18.9% and 21.7% lower respectively, and the 3 year and 5 year returns were 73.4% and 81.3% lower. This gives important context before judging any potential upside or downside. Recent coverage around STAAR...

If you are asking whether NCR Atleos at US$37.63 is a bargain, fully priced, or something in between, this article is going to walk you through the key signals that matter for valuation. The stock has moved around recently, with a 5.8% decline over the last 7 days, a 3.5% decline over the last 30 days, and returns of 1.1% year to date and 15.7% over the last year. Recent coverage has focused on NCR Atleos as a stand alone ATM and financial technology infrastructure business following its...

Riverwater Partners Sustainable Value Strategy has initiated a new position in Adeia Inc. (NasdaqGS:ADEA). The position reflects fresh institutional interest in Adeia's intellectual property business across media and semiconductor markets. Adeia focuses on licensing intellectual property that underpins media content distribution and semiconductor design, areas that remain central to how video is delivered and how chips are structured and manufactured. As streaming, connected devices and...

Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and health systems with medication management. These moves highlight Omnicell's efforts to align its portfolio with outcome focused digital healthcare trends. At a share price of $50.3, Omnicell is coming off a mixed return profile, with the stock up 8.4% over the past 30 days and 11.4% year to...

Arbe Robotics (ARBE) is attracting fresh attention after a sharp move in both its shares and options, with recent trading sessions showing concentrated call option activity and heavier volumes than the average month. See our latest analysis for Arbe Robotics. The latest options activity comes after a volatile stretch where the 7 day share price return of 49.12% and 30 day share price return of 65.05% contrast with a 1 year total shareholder return loss of 43.14%. This suggests short term...

If you are wondering whether Interparfums at around US$98.76 is attractively priced or asking too much for its brand power, you are in the right place. The stock has recently shown sharp moves, with returns of 9.8% over 7 days and 15.8% over 30 days. It also carries a 27.8% decline over 1 year and a 6.1% decline over 3 years, alongside a 77.3% gain over 5 years. These mixed returns come against a backdrop of ongoing attention on branded fragrance and beauty companies, where investors have...

If you are wondering whether Assurant at around US$233 per share still offers value, you are not alone. The stock’s current price invites a closer look at what you are actually paying for. The share price closed at US$233.39, with returns of a 0.3% decline over 7 days, a 3.5% decline over 30 days and a 1.8% decline year to date, while the 1 year and 3 year returns stand at 12.4% and 88.5% respectively, and the 5 year return is 87.9%. Recent price moves sit against a backdrop of ongoing...

Oruka Therapeutics, Inc. recently reported positive interim data from its first-in-human Phase 1 trial of ORKA-002, showing a long half-life, sustained IL-17 inhibition and a class-consistent safety profile in healthy volunteers, while outlining multiple ongoing and planned psoriasis and hidradenitis suppurativa studies across its ORKA-001 and ORKA-002 programs. A key insight for investors is the early clinical evidence suggesting ORKA-002 may enable twice-yearly maintenance dosing,...

Earlier this month, Qnity Electronics reaffirmed its full-year 2025 net sales guidance of about US$4.70 billion and announced that long-time finance executive Mike Goss will serve as Interim Chief Financial Officer following Matt Harbaugh’s health-related departure. The combination of steady guidance and a seasoned interim CFO, who brings nearly three decades of experience at DuPont and Ernst & Young, has sharpened investor focus on Qnity’s role as a newly independent supplier of...

Caledonia Mining (CMCL) has packed a lot into its latest update, combining Q4 and full year 2025 production figures, fresh 2026 guidance, a COO departure, and new convertible bond financing. See our latest analysis for Caledonia Mining. Those production figures, new 2026 guidance, COO departure and fresh convertible notes have landed alongside a strong share price move. The 1 day share price return is 6.05%, the 7 day return is 15.36%, the 30 day return is 15.91% and the year to date return...

POET Technologies recently completed a registered direct follow-on equity offering of 20,689,656 common shares at US$7.25 each, raising about US$150.00 million to fund acquisitions, research and development, and expansion of its optical module and light source businesses. This capital raise follows POET’s Product Innovation Award in China for its Teralight 1.6T optical engines, highlighting management’s intent to scale its AI-focused photonics platform using fresh institutional...

BillionToOne (BLLN) is back on investors’ radar after recent trading, with the share price around US$87.57 and mixed short term returns, including a 3.3% decline over the past day and a modest gain over the month. See our latest analysis for BillionToOne. Despite the recent 3.3% one day share price decline and a slightly negative year to date share price return of 1.93%, BillionToOne’s 1.42% 30 day share price return suggests momentum has been cautious rather than strongly trending in either...

Datavault AI Inc. recently presented at the ICR Conference 2026 in Orlando and is set to appear at the DealFlow Discovery Conference in Atlantic City, where CEO Nathaniel T. Bradley is discussing the company’s focus on real-world asset tokenization and broader technology portfolio. These conference appearances highlight Datavault AI’s effort to raise its profile with institutional investors and analysts by showcasing its tokenization strategy and long-term growth initiatives through formal...

Associated Banc-Corp (ASB) has wrapped up FY 2025 with fourth quarter revenue of US$382.4 million and basic EPS of US$0.81. Trailing twelve month revenue came in at US$1.43 billion with EPS of US$2.81. The company has seen revenue move from US$952.9 million and EPS of US$0.73 on a trailing basis at the end of 2024 to US$1.43 billion and EPS of US$2.81 by the end of 2025, setting the backdrop for what investors will focus on as potential rewards from reported growth forecasts and expanding...

Aeva Technologies (AEVA) has just secured its first defense sector contract, with Forterra selecting its 4D LiDAR sensors and perception technology for the AutoDrive autonomous vehicle system used in demanding mission environments. See our latest analysis for Aeva Technologies. The Forterra win lands after a busy start to the year, including Aeva’s new high power optical amplifier for AI data centers and its appearance at the Needham Growth Conference. Yet the share price has been volatile,...

In mid-January 2026, QXO, Inc. completed a follow-on equity offering of approximately US$753.16 million, issuing 31,645,570 common shares at US$23.80 each with a US$0.10 discount per share. This transaction forms part of a broader US$3 billion equity funding effort, signaling substantial financial backing for QXO’s acquisition-focused push in building products distribution and specialty contractor supply. With this sizeable equity raise underpinning its acquisition ambitions, we will examine...

If you are wondering whether Brookdale Senior Living's share price still offers value after a strong run, this article walks through what the current market price might be implying about the company. The stock last closed at US$12.95, with returns of 6.1% over 7 days, 18.9% over 30 days, 19.5% year to date, 163.2% over 1 year, 339.0% over 3 years, and 162.1% over 5 years, which has put it firmly on many investors' radar. Recent coverage around Brookdale Senior Living has focused on its...

If you are trying to figure out whether RH at around US$228 per share looks like a bargain or a value trap, it helps to first step back and look at what the recent share price has been telling you. The stock has seen mixed returns, with a 1.9% decline over the last 7 days, a 24.8% gain over the last 30 days, an 18.1% gain year to date, but also a 45.5% decline over 1 year, a 26.5% decline over 3 years and a 52.0% decline over 5 years. These swings suggest sentiment around RH has shifted more...

RPM International (RPM) is back in focus after JPMorgan upgraded the stock and the company outlined about US$100 million in annual SG&A savings, alongside guidance for modest sales and adjusted EBIT growth. See our latest analysis for RPM International. At a share price of US$109.48, RPM has a modest 30 day share price return of 3.49%, while its 1 year total shareholder return of 11.75% decline contrasts with a 31.33% gain over three years and 45.37% over five years. This suggests longer term...

Lakeland Financial (NasdaqGS:LKFN) has appointed Donald J. Robinson-Gay as Executive Vice President and Chief Credit Officer of Lakeland Financial and Lake City Bank. The appointment places Robinson-Gay in charge of credit policy, loan portfolio oversight, and risk practices across the organization. Lakeland Financial, the parent of Lake City Bank, operates as a regional banking institution focused on serving business and retail clients through lending, deposit, and treasury services. For...

Follow on offering sets the stage Coherus Oncology (CHRS) has filed a follow on equity offering of about US$64.9 million through an at the market program. This is a material move that directly affects funding plans and existing shareholders. See our latest analysis for Coherus Oncology. The follow on offering arrives after a sharp rebound in sentiment, with a 1 month share price return of 53.73% and year to date share price return of 50.37%. However, the 5 year total shareholder return of an...

Cabaletta Bio (CABA) is back in focus after Cellares received FDA clearance for an IND amendment supporting automated manufacturing and quality testing of Cabaletta’s investigational CAR T therapy, rese cel, using Cell Shuttle and Cell Q platforms. See our latest analysis for Cabaletta Bio. The FDA clearance news arrives after a sharp shift in sentiment, with Cabaletta Bio’s 7 day share price return of 44.55% and 30 day return of 45.21% contrasting with a 3 year total shareholder return...

Navigator Gas recently reported strong operational and financial performance, highlighting record earnings, robust cash flows, and ongoing fleet expansion across its gas shipping business. A key development is the company’s ethylene export terminal, which management views as an important growth engine alongside new vessel deliveries through 2028. Next, we’ll explore how this combination of record earnings and fleet expansion could influence Navigator Holdings’ broader investment...

Earlier this week, WhiteFiber, Inc. completed a US$210,000,000 private placement of 4.500% convertible senior unsecured notes due February 1, 2031, primarily to fund data center expansion, potential acquisitions, partnerships, and related equipment. The offering’s callable, convertible structure and planned zero-strike call option arrangement introduce meaningful capital-structure and dilution considerations for both existing and prospective investors. Next, we’ll examine how this upsized...